VEGFA and nonpapillary renal cell carcinoma: Over the past two decades, treatment strategies for advanced ccRCC have evolved significantly with the widespread use of VEGF tyrosine kinase inhibitors (TKIs), immune checkpoint inhibitors (ICIs), and combinations of these approaches [2, 3, 4, 5].